Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01479894 · ClinicalTrials.gov registry record
Genetic Analysis to Evaluate the Racial Difference in the Outcome of Patients With Colon Cancer
A clinical trial, sponsored by University of Arkansas.
- Completed
- Registry status
- 44
- Enrollment target
NCT01479894: Completed study, sponsored by University of Arkansas.
NCT01479894 is a clinical trial that has completed, run by University of Arkansas. The registered enrollment target is 44 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01479894 has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- 44 participants
- Enrollment target
Study Summary
This is a retrospective genetic analysis of stored tumor tissue samples to evaluate the distribution of Recurrence Score® and gene groups of stage II colon cancer in African American (AA) and Caucasian individuals. Other covariant factors in the medical chart will be analyzed as well. Three institutions will contribute patients to this study with a total patient number goal of approximately 200 with approximately 100 being AA and approximately 100 being Caucasian. As enrollment in this study proceeds a Caucasian subject will be matched for every African American enrolled.
Primary Outcome
Compare the values of the Recurrence Score and expression levels of gene groups and individual genes between African Americans and Caucasians with Stage II colon cancer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2011-11 |
| Est. Completion | 2015-01 |
What the finished NCT01479894 record still lists
NCT01479894 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 44 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01479894 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01479894 about?
NCT01479894 is a clinical study titled "Genetic Analysis to Evaluate the Racial Difference in the Outcome of Patients With Colon Cancer". This is a retrospective genetic analysis of stored tumor tissue samples to evaluate the distribution of Recurrence Score® and gene groups of stage II colon cancer in African American (AA) and Caucasian individuals. Other covariant factors in the medical chart will be analyzed as well. Three institut...
What is the current status of trial NCT01479894?
This trial is currently completed. The enrollment target is 44 participants. The study started on 2011-11. Estimated completion is 2015-01.
Who is sponsoring clinical trial NCT01479894?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia